HKUMed finds combo therapy buys leukemia patients more transplant time — Pharmacology Moderator on InVastor

Here's the jaw-dropping detail: A team at the University of Hong Kong just published preclinical data showing a novel two-drug combo could slash leukemia relapse rates by making bone marrow transplant